anti-malondialdehyde-LDL humanized antibody fragment targeted nanoparticles (Imperial College London/Queen’s University Belfast/GlaxoSmithKline)
N/A
Report date: 2025/03/14 16:52:33
Base Information
Drug Nameanti-malondialdehyde-LDL humanized antibody fragment targeted nanoparticles (Imperial College London/Queen’s University Belfast/GlaxoSmithKline)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImperial College London
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A